EX-99.1 2 ss60863_ex9901.htm JOINT FILING AGREEMENT

EXHIBIT 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on this Schedule 13D, dated September 28, 2017 (the “Schedule 13D”), with respect to the Common Stock, of Roka Bioscience, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D.  Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein.  This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 28th    day of September, 2017.
 
OrbiMed Advisors LLC
   
         
 
By:
/s/ Samuel D. Isaly
  
   
Name:
Samuel D. Isaly
   
Title:
Managing Member
   
   
 
OrbiMed Capital GP III LLC
   
 
By:
OrbiMed Advisors LLC
   
   
 
By:
/s/ Samuel D. Isaly
  
   
Name:
Samuel D. Isaly
   
Title:
Managing Member
   
   
 
Samuel D. Isaly
   
   
 
By:
/s/ Samuel D. Isaly
  
   
Name:
Samuel D. Isaly